Devintec Pharma is a Swiss-based pharmaceutical company specialising in B2B partnerships through the out-licensing of innovative substance-based medical devices. The company adheres to strict clinical and regulatory standards, delivering evidence-based treatments that focus on addressing root causes and restoring natural permeability. Using their proprietary DevinPro™ technology, which creates a protective barrier for lasting relief, Devintec Pharma has developed patented products in the fields of gastroenterology, dermatology, and gynecology. Their research prioritises clinically-proven, non-pharmaceutical solutions, demonstrating strong safety and efficacy.

Services include:
– Finished Dosage Forms
– Out-licensing of medical devices
– Development of substance-based therapies
– Clinical research and regulatory support

Devintec Pharma is committed to providing innovative solutions that enhance patient care and ensure quality outcomes in the pharmaceutical industry. For more information, please visit devintecpharma.com.